Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 75533.76 1074.23 (1.44%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
91	Rainbow Childrens Medicare Ltd.	Q V PT	12,366 Small Cap	1,230.55 (1.07%)	42.32	7.21	21.24	43.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Zydus Lifesciences Ltd.	Q V PT	1,24,089 Mid Cap	1,238.20 (-0.47%)	27.5	4.6	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Venus Remedies Ltd.	Q V+ PT	1,646 Small Cap	1,281.50 (4.04%)	13.53	2.34	7.02	18.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	Global Health Ltd.	Q V PT	34,122 Small Cap	1,315.65 (3.67%)	61.35	8.3	24.97	76.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	3B Blackbio Dx Ltd.	Q V PT	1,113 Small Cap	1,337 (3.14%)	20.04	3.34	-8.95	-14.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Dr. Reddys Laboratories Ltd.	Q V PT	1,12,699 Mid Cap	1,356.70 (0.48%)	40.25	2.9	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Cipla Ltd.	Q V PT	1,11,489 Large Cap	1,377.60 (-0.17%)	38.48	3.15	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Fredun Pharmaceuticals Ltd.	Q V+ PT	2,340 Small Cap	1,409.60 (3.19%)	53.39	7.67	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Vijaya Diagnostic Centre Ltd.	Q V+ PT	14,906 Small Cap	1,438.55 (-0.60%)	79.51	14.8	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Alivus Life Sciences Ltd.	Q V+ PT	17,311 Small Cap	1,441.80 (2.42%)	25.85	4.77	6.24	6.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Poly Medicure Ltd.	Q V PT	14,676 Small Cap	1,463.95 (1.11%)	46.58	4.61	18.98	16.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Sai Life Sciences Ltd.	Q V+ PT	33,139 Small Cap	1,564.55 (0.31%)	91.61	12.98	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Onesource Specialty Pharma Ltd.	Q V PT	17,926 Small Cap	1,578.70 (0.99%)	N/A	3.03	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	Aurobindo Pharma Ltd.	Q V+ PT	96,537 Mid Cap	1,666.40 (-0.68%)	37.23	4.12	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Rubicon Research Ltd.	Q V+ PT	26,650 Small Cap	1,669.90 (3.73%)	92.47	19.85	41.00	54.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Evonile Pharma Ltd.	Q V+ PT	4,182 Small Cap	1,753.10 (3.50%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Sun Pharmaceutical Industries Ltd.	Q V PT	4,26,662 Large Cap	1,767.20 (-0.62%)	38.91	4.78	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Narayana Hrudayalaya Ltd.	Q V PT	35,144 Small Cap	1,840.30 (7.01%)	40.92	7.02	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Dr. Lal Pathlabs Ltd.	Q V PT	31,997 Small Cap	1,874 (-1.69%)	58.73	12.44	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Emcure Pharmaceuticals Ltd.	Q V PT	35,440 Small Cap	1,880.10 (0.64%)	35.04	6.78	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Wockhardt Ltd.	Q V+ PT	30,814 Small Cap	1,882.75 (-0.70%)	75.34	6.12	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Ipca Laboratories Ltd.	Q V+ PT	48,907 Mid Cap	1,966 (1.99%)	39.32	5.86	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,025.35 (0.81%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	CORONA Remedies Ltd.	Q V+ PT	13,125 Small Cap	2,194.90 (2.28%)	63.4	16.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Hester Biosciences Ltd.	Q V PT	1,956 Small Cap	2,282.30 (-0.76%)	14.37	4.3	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Caplin Point Laboratories Ltd.	Q V PT	17,672 Small Cap	2,342.70 (0.77%)	26.56	4.81	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Laurus Labs Ltd.	Q V+ PT	1,29,243 Mid Cap	2,373.40 (-0.78%)	96.46	21.33	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	Glenmark Pharmaceuticals Ltd.	Q V+ PT	65,137 Mid Cap	2,382.75 (3.24%)	36.23	5.94	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Mankind Pharma Ltd.	Q V PT	1,02,797 Mid Cap	2,510.55 (0.88%)	45.84	5.85	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	RPG Life Sciences Ltd.	Q V+ PT	4,255 Small Cap	2,525.50 (-1.82%)	38.89	6.19	42.67	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Narayana Hrudayalay.	1,840.30	7.01%
Advanced Enzyme Tech	279.60	6.33%
Indegene	622.10	5.86%
Themis Medicare	99.84	5.09%
Max Healthcare Inst.	900	4.65%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Sigachi Industries	25.02	-5.23%
Morepen Laboratories	108.05	-4.97%
Concord Biotech	1,189.65	-4.47%
Bliss GVS Pharma	624.10	-3.75%
Artemis MedicareServ	281.55	-3.64%

News about Top Pharma Companies in India

Nov, 2026

RainbowChildrenS Med - Quaterly Results

A fair growth of 19.22% in the revenue at Rs. 4869.91 millions was reported in the September 2026 quarter as compared to Rs. 4084.96 millions during year-ago period.A meek growth of 2.63% was reported for the quarter ended September 2026 to Rs. 750.93 millions from Rs. 731.67 millions.Operating Profit saw a handsome growth to 1595.88 millions from 1488.91 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	4869.91	4084.96	19.22	8975.38	7432.44	20.76	15456.60	14545.06	6.27
Other Income	80.92	81.73	-0.99	208.49	274.58	-24.07	434.54	489.49	-11.23
PBIDT	1595.88	1488.91	7.18	2870.04	2676.97	7.21	5433.11	5234.23	3.80
Interest	199.14	173.09	15.05	391.63	347.02	12.86	713.96	695.94	2.59
PBDT	1396.74	1315.82	6.15	2478.41	2329.95	6.37	4703.76	4538.29	3.65
Depreciation	398.09	331.82	19.97	774.35	657.75	17.73	1362.61	1317.48	3.43
PBT	998.65	984.00	1.49	1704.06	1672.20	1.91	3341.15	3220.81	3.74
TAX	247.72	252.33	-1.83	426.07	423.33	0.65	840.99	844.98	-0.47
Deferred Tax	-57.47	-27.87	106.21	-68.71	-22.06	211.47	-73.38	-31.54	132.66
PAT	750.93	731.67	2.63	1277.99	1248.87	2.33	2500.16	2375.83	5.23
Equity	1015.66	1015.59	0.01	1015.66	1015.59	0.01	1015.59	1015.52	0.01
PBIDTM(%)	32.77	36.45	-10.09	31.98	36.02	-11.22	35.15	35.99	-2.32

Oct, 2026

Corona Remedies informs about newspaper publication

Corona Remedies has informed that the Board of Directors, at its meeting held on Friday, October 30, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the second quarter and half year ended on September 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Sun Pharma. Inds. - Quaterly Results

The sales surged to Rs. 61419.20 millions, up 35.04% for the September 2026 quarter as against Rs. 45481.10 millions during the corresponding quarter previous year.Profit after tax for the quarter ended September 2026 reported a huge growth of 54.42% to Rs. 8712.90 millions from Rs. 5642.20 millions.Operating Profit saw a handsome growth to 17957.40 millions from 12563.80 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	61419.20	45481.10	35.04	118830.50	101429.90	17.16	207546.40	229774.00	-9.67
Other Income	810.10	727.90	11.29	2211.80	1765.00	25.31	4193.30	3791.40	10.60
PBIDT	17957.40	12563.80	42.93	39001.20	32696.20	19.28	66000.20	72168.40	-8.55
Interest	2769.60	2483.30	11.53	5554.40	4867.50	14.11	9478.40	9538.90	-0.63
PBDT	15187.80	10080.50	50.67	33131.50	24952.30	32.78	51058.40	62629.50	-18.48
Depreciation	3157.90	3363.00	-6.10	6237.10	6472.20	-3.63	13117.20	12867.40	1.94
PBT	12029.90	6717.50	79.08	26894.40	18480.10	45.53	37941.20	49762.10	-23.75
TAX	3317.00	1075.30	208.47	7030.10	5387.30	30.49	11707.00	7481.30	56.48
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	8712.90	5642.20	54.42	19864.30	13092.80	51.72	26234.20	42280.80	-37.95
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	29.24	27.62	5.84	32.82	32.24	1.82	31.80	31.41	1.25

Oct, 2026

Narayana Hrudayalay. - Quaterly Results

The revenue zoomed 16.31% to Rs. 11853.77 millions for the quarter ended September 2026 as compared to Rs. 10191.69 millions during the corresponding quarter last year.Good Net Profit growth of 27.38% reported above the corresponding previous quarter figure of Rs. 1378.80 millions to Rs. 1756.26 millioins.Operating profit for the quarter ended September 2026 rose to 3045.61 millions as compared to 2461.39 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	11853.77	10191.69	16.31	22824.79	19623.10	16.32	39751.41	35901.22	10.72
Other Income	433.50	170.88	153.69	737.63	335.24	120.03	1764.34	1421.63	24.11
PBIDT	3045.61	2461.39	23.74	5740.96	4415.93	30.01	10158.82	8137.02	24.85
Interest	352.30	285.78	23.28	688.96	592.01	16.38	1271.16	877.08	44.93
PBDT	2693.31	2175.61	23.80	5052.00	3823.92	32.12	8434.90	7259.94	16.18
Depreciation	501.09	462.66	8.31	982.57	938.24	4.72	1914.78	1692.63	13.12
PBT	2192.22	1712.95	27.98	4069.43	2885.68	41.02	6520.12	5567.31	17.11
TAX	435.96	334.15	30.47	934.62	633.17	47.61	1488.99	1255.89	18.56
Deferred Tax	17.03	18.36	-7.24	34.58	30.77	12.38	-75.93	187.21	-140.56
PAT	1756.26	1378.80	27.38	3134.81	2252.51	39.17	5031.13	4311.42	16.69
Equity	2043.61	2043.61	0.00	2043.61	2043.61	0.00	2043.61	2043.61	0.00
PBIDTM(%)	25.69	24.15	6.39	25.15	22.50	11.77	25.56	22.67	12.75

Oct, 2026

Sun Pharma’s consolidated net profit falls 36% in Q2

The total consolidated income of the company has increased by 11.83% at Rs 16,716.03 crore for Q2FY27

Oct, 2026

OneSource Specialty inches up on getting USFDA’s EIR with VAI classification for Bengaluru SPD facility

The report follows an inspection of the facility conducted from June 22 to June 30, 2026

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Gennex Laboratories Ltd.	195 Crore
2	Take Ltd.	159 Crore
3	Medico Remedies Ltd.	155 Crore
4	Syncom Formulations (India) Ltd.	1,810 Crore
5	Sigachi Industries Ltd.	1,009 Crore
6	Anlon Healthcare Ltd.	1,378 Crore
7	Fischer Medical Ventures Ltd.	1,729 Crore
8	Ambalal Sarabhai Enterprises Ltd.	268 Crore
9	Shukra Medtech Ltd.	3,317 Crore
10	Anuh Pharma Ltd.	873 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,738	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,598	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,383	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,025	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,373	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,666	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,966	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,511	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,426	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,238	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,069	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,565	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,025	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,383	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,738	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,357	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

RainbowChildrenS Med - Quaterly Results

Corona Remedies informs about newspaper publication

Sun Pharma. Inds. - Quaterly Results

Narayana Hrudayalay. - Quaterly Results

Sun Pharma’s consolidated net profit falls 36% in Q2

OneSource Specialty inches up on getting USFDA’s EIR with VAI classification for Bengaluru SPD facility

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?